相关实验视频
Updated: Jun 10, 2025

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
对肠道衰竭的分类和管理的多学科方法:知识在进步
Sol Ramírez-Ochoa1, Luis Asdrúval Zepeda-Gutiérrez1, Mauricio Alfredo Ambriz-Alarcón2
1Department of Internal Medicine, Hospital Civil de Guadalajara Fray Antonio Alcalde, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.
最近在治疗肠衰竭 (IF) 方面的进展改善了患者的治疗结果. 本综述强调了GLP-2类似物和专业中心等关键发展,同时指出了儿科和成人群体面临的年龄特定挑战.
科学领域:
- 胃肠病学和肝病学 胃肠学和肝病学
- 儿科胃肠病学 儿科胃肠病学
- 临床营养学 临床营养学
背景情况:
- 肠道功能衰竭 (IF) 损害了营养和液体的吸收,严重影响生活质量.
- 短肠综合症 (SBS) 是IF的全球主要原因.
- 儿科IF幸存者面临着独特的长期挑战,与成人发病的IF不同.
研究的目的:
- 对成人和儿童群体的IF管理中最近的进展进行审查.
- 突出IF病因,治疗和年龄组之间的结果之间的差异.
- 强调IF中需要特定年龄的管理策略.
主要方法:
- 关于肠道衰竭管理的最新研究的综合文献综述.
- 对IF的营养和医疗疗法的进展进行分析.
- 儿科与成人患者的IF管理和结果的比较.
主要成果:
- 报告了IF死亡率的显著降低和生活质量的改善.
- 关键的进步包括GLP-2类似物,改善的腹腔营养和专门的中心.
- 儿科IF幸存者需要为生长,发育和肝脏疾病提供量身定制的支持.
结论:
- 治疗IF的治疗场景正在随着新的治疗方法和更好的病理生理学理解而发展.
- 儿童和成人之间结果的差异需要年龄特定的IF管理.
- 结合医疗进步和与年龄相关的不同需求的细微方法对于有效的IF护理至关重要.
更多相关视频
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
07:06Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Heart Failure IV: Classification and Diagnostic Evaluation